Skip to main content

Table 4 Summary of the effects of SGLT-2 inhibitors on cardiac inflammation in animal models

From: Potential mechanisms responsible for cardioprotective effects of sodium–glucose co-transporter 2 inhibitors

Animal species

Model

Drug/dose/route

Major findings

Interpretation

References

SHR/NDmcr-cp (+/+) rats

Prediabetes/metabolic syndrome

0.03% empagliflozin/diet/10 weeks

↓ Cardiac interstitial macrophage infiltration

Empagliflozin attenuated cardiac macrophage infiltration in genetic prediabetic metabolic syndrome rats

[57]

db/db mice

Diabetes/obesity (diastolic dysfunction and LVH)

0.03% empagliflozin/diet/10 weeks

↓ Cardiac macrophage infiltration

Empagliflozin attenuated cardiac macrophage infiltration in db/db mice

[58]

BTBR ob/ob mice

T2DM

Dapagliflozin (1 mg/kg/days)/PO/8 weeks

↓ NALP-3, ASC, caspase-1, IL-1β, IL-6 and TNFα expressions

Dapagliflozin attenuated NLRP3 inflammasome and inflammatory markers in BTBR ob/ob mice

[63]

BTBR ob/ob mice

In vitro cardiofibroblast culture

Dapagliflozin (0.1–0.5 μM)/media/16 h

↓ NALP-3, ASC, caspase-1 and IL-1β expressions in dose dependent manner

Dapagliflozin attenuated NLRP3 inflammasome and inflammatory markers in cardiofibroblasts of BTBR ob/ob mice

These effects are independent from SGLT-2 and glucose reducing effects of dapagliflozin

[63]

Wistar rats

MI by LAD ligation in rats

Dapagliflozin (0.1 mg/kg/days)/PO/Start after 1-day infarction for 2 days

↑ M2/M1 phenotype macrophage ratio and IL-10 mRNA level

↓ IL-1β and IL-6 mRNA levels

Dapagliflozin promoted macrophages toward anti-inflammatory phenotype, increased anti-inflammatory cytokine and attenuated inflammatory cytokines in rats with acute stage of MI

[65]

cmlc2::GFP zebrafish embryos

Aristolochic acid induced heart failure

Empagliflozin (0.1, 10 μM)/media/3 days

↓ Cox-2, IL-1β expressions

Empagliflozin attenuated pro-inflammatory genes in heart failure zebrafish model

[66]

  1. SGLT-2 sodium–glucose co-transporter 2, LVH left ventricular hypertrophy, T2DM type 2 diabetic mellitus, NALP-3 NACHT, LRR and PYD domains-containing protein 3, ASC apoptosis-associated speck-like protein containing a caspase recruitment domain, IL interleukin, TNFα tumor necrosis factor α, NLRP3 nucleotide-binding oligomerization domain-like receptor 3, MI myocardial infarction, LAD left anterior descending artery, Cox-2 cyclooxygenase-2